UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy

European heart journal, 2020-05, Vol.41 (19), p.1821-1829

2020

Volltextzugriff (PDF)

COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease

European journal of heart failure, 2020-06, Vol.22 (6), p.957-966

2020

Volltextzugriff (PDF)

Reply to Misleading Impact of Mitral Regurgitation on the Evaluation of Left Ventricular Contractile Function in Heart Failure With Preserved Ejection Fraction

Journal of cardiac failure, 2024-08, Vol.30 (8), p.1067-1068

2024

Volltextzugriff (PDF)

Identification and quantification of congestion in heart failure: a work in progress

European journal of heart failure, 2023-01, Vol.25 (1), p.61-62

2023

Volltextzugriff (PDF)

Epicardial Adipose Tissue in Heart Failure: Risk Factor or Mediator?

European journal of heart failure, 2022-08, Vol.24 (8), p.1357-1358

2022

Volltextzugriff (PDF)

Criteria for Iron Deficiency in Patients With Heart Failure

Journal of the American College of Cardiology, 2022-02, Vol.79 (4), p.341-351

2022

Volltextzugriff (PDF)

Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure

European heart journal, 2023-12, Vol.44 (48), p.5061-5063

2023

Volltextzugriff (PDF)

Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?

European heart journal, 2020-08, Vol.41 (32), p.3094-3094

2020

Volltextzugriff (PDF)

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)

JAMA cardiology, 2020-07, Vol.5 (7), p.819

2020

Volltextzugriff (PDF)

Editorial commentary: Long COVID-19: A tangled web of lungs, heart, mind, and gender

Trends in cardiovascular medicine, 2022-01, Vol.32 (1), p.18-19

2022

Volltextzugriff (PDF)

Mitral regurgitation and heart failure with preserved ejection fraction: Should we treat the muscle, the valve, or both?

European journal of heart failure, 2024-06, Vol.26 (6), p.1443-1445

2024

Volltextzugriff (PDF)

ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19

European heart journal, 2020-09, Vol.41 (33), p.3200-3200

2020

Volltextzugriff (PDF)

Mitral regurgitation, edge‐to‐edge valve repair and the left atrium: one step beyond the left ventricle?

European journal of heart failure, 2020-07, Vol.22 (7), p.1211-1213

2020

Volltextzugriff (PDF)

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure

Current heart failure reports, 2023-08, Vol.20 (4), p.308-319

2023

Volltextzugriff (PDF)

Usefulness of strain imaging echocardiography in arrhythmogenic right ventricular cardiomyopathy: clinical perspective

The International Journal of Cardiovascular Imaging, 2020-02, Vol.36 (2), p.269-270

Inciardi, Riccardo M.

2020

Volltextzugriff (PDF)

Left atrium: a forgotten biomarker and a potential target in cardiovascular medicine

Journal of cardiovascular medicine (Hagerstown, Md.), 2019-12, Vol.20 (12), p.797

2019

Volltextzugriff (PDF)

Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics

European journal of heart failure, 2020-03, Vol.22 (3), p.499-506

2020

Volltextzugriff (PDF)

Association of Left Atrial Structure and Function With Heart Failure in Older Adults

Journal of the American College of Cardiology, 2022-04, Vol.79 (16), p.1549-1561

2022

Volltextzugriff (PDF)

Cardiac mechanics assessment and the risk of heart failure in the general population

European journal of heart failure, 2021-11, Vol.23 (11), p.1828-1830

2021

Volltextzugriff (PDF)

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction

Circulation (New York, N.Y.), 2022-06, Vol.145 (23), p.1741-1743

2022

Volltextzugriff (PDF)

Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment

European journal of heart failure, 2022-06, Vol.24 (6), p.959-975

2022

Volltextzugriff (PDF)

Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease

Journal of the American Heart Association, 2020-08, Vol.9 (16), p.e017756-e017756

2020

Volltextzugriff (PDF)

Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study

European journal of heart failure, 2020-12, Vol.22 (12), p.2238-2247

2020

Volltextzugriff (PDF)

Left atrial structure and function and the risk of death or heart failure in atrial fibrillation

European journal of heart failure, 2019-12, Vol.21 (12), p.1571-1579

2019

Volltextzugriff (PDF)

Left atrial strain importance in atrial fibrillation screening process

Annals of cardiothoracic surgery, 2024-03, Vol.13 (2), p.173-175

2024

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(140)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy

COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease

Reply to Misleading Impact of Mitral Regurgitation on the Evaluation of Left Ventricular Contractile Function in Heart Failure With Preserved Ejection Fraction

Identification and quantification of congestion in heart failure: a work in progress

Epicardial Adipose Tissue in Heart Failure: Risk Factor or Mediator?

Criteria for Iron Deficiency in Patients With Heart Failure

Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure

Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)

Editorial commentary: Long COVID-19: A tangled web of lungs, heart, mind, and gender

Mitral regurgitation and heart failure with preserved ejection fraction: Should we treat the muscle, the valve, or both?

ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19

Mitral regurgitation, edge‐to‐edge valve repair and the left atrium: one step beyond the left ventricle?

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure

Usefulness of strain imaging echocardiography in arrhythmogenic right ventricular cardiomyopathy: clinical perspective

Left atrium: a forgotten biomarker and a potential target in cardiovascular medicine

Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics

Association of Left Atrial Structure and Function With Heart Failure in Older Adults

Cardiac mechanics assessment and the risk of heart failure in the general population

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction

Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment

Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease

Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study

Left atrial structure and function and the risk of death or heart failure in atrial fibrillation

Left atrial strain importance in atrial fibrillation screening process

Suchergebnisse filtern